Enzalutamide Inhibits Triple-negative Breast Cancer Metastasis by simply Attenuating Anoikis Level of resistance through Inhibition associated with Skp2-mediated Transcriptional Dependency. Website: https://www.selleckchem.com/products/MDV3100.html